Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.
Agarwal S, Sasane S, Deshmukh P, Rami B, Bandyopadhyay D, Giri P, Giri S, Jain M, Desai RC. Agarwal S, et al. ACS Med Chem Lett. 2016 Sep 21;7(12):1134-1138. doi: 10.1021/acsmedchemlett.6b00331. eCollection 2016 Dec 8. ACS Med Chem Lett. 2016. PMID: 27994752 Free PMC article.
Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.
Agarwal S, Patil A, Aware U, Deshmukh P, Darji B, Sasane S, Sairam KV, Priyadarsiny P, Giri P, Patel H, Giri S, Jain M, Desai RC. Agarwal S, et al. ACS Med Chem Lett. 2015 Nov 20;7(1):51-5. doi: 10.1021/acsmedchemlett.5b00323. eCollection 2016 Jan 14. ACS Med Chem Lett. 2015. PMID: 26819665 Free PMC article.
Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.
Agarwal S, Sasane S, Shah HA, Pethani JP, Deshmukh P, Vyas V, Iyer P, Bhavsar H, Viswanathan K, Bandyopadhyay D, Giri P, Mahapatra J, Chatterjee A, Jain MR, Sharma R. Agarwal S, et al. ACS Med Chem Lett. 2020 Feb 27;11(4):414-418. doi: 10.1021/acsmedchemlett.9b00433. eCollection 2020 Apr 9. ACS Med Chem Lett. 2020. PMID: 32292543 Free PMC article.
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.
Agarwal S, Pethani JP, Shah HA, Vyas V, Sasane S, Bhavsar H, Bandyopadhyay D, Giri P, Viswanathan K, Jain MR, Sharma R. Agarwal S, et al. Bioorg Med Chem Lett. 2020 Nov 1;30(21):127571. doi: 10.1016/j.bmcl.2020.127571. Epub 2020 Sep 24. Bioorg Med Chem Lett. 2020. PMID: 32980515 Free PMC article.
A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease.
Chatterjee A, Mohapatra J, Sharma M, Jha A, Patro R, Das D, Patel H, Patel H, Chaudhari J, Borda N, Viswanathan K, Sharma B, Bhavsar H, Patel A, Ranvir R, Sundar R, Agarwal S, Jain M. Chatterjee A, et al. Among authors: agarwal s. Brain Res. 2024 Nov 1;1842:149129. doi: 10.1016/j.brainres.2024.149129. Epub 2024 Jul 27. Brain Res. 2024. PMID: 39074525
Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68Ga-DATA5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients.
Ballal S, Sheokand P, Yadav MP, Roesch F, Viswanathan R, Satapathy S, Tripathi M, Moon ES, Mishra P, Rastogi S, Agarwal S, Bal C. Ballal S, et al. Among authors: agarwal s. Clin Nucl Med. 2025 Jan 6. doi: 10.1097/RLU.0000000000005649. Online ahead of print. Clin Nucl Med. 2025. PMID: 39761436
7,200 results